Amy Finan

Amy Finan is the Chief Executive Officer of the Sabin Vaccine Institute, a position she has held since April 2016.1 As CEO, she has led the development and implementation of a new organizational strategy focused on making vaccines more accessible, enabling innovation, and expanding immunization globally.1

Career Highlights

Under Finan's leadership, Sabin has achieved several notable accomplishments:

• Launched a new R&D program in 2019, securing a license from GSK to develop vaccines against Ebola Sudan and Marburg viruses1
• Rebuilt Sabin's immunization programs and strengthened relationships with global organizations like WHO, Gavi, UNICEF, and the Bill & Melinda Gates Foundation1
• Expanded disease surveillance programs to aid countries in vaccine introduction decisions1
• Implemented educational programs for journalists to report accurately on vaccines1

Previous Experience

Before joining Sabin, Finan's career included:

• Senior Vice President at the Biotechnology Innovation Organization (BIO) for 11 years1
• President of the Biotechnology Institute1
• Corporate communications and investor relations lead at EntreMed, Inc.1
• Director of government relations at the National Association for Biomedical Research1

Education and Personal

Amy Finan studied at the London School of Economics & Political Science and graduated with a bachelor's degree in political science from Trinity College in Washington, D.C.1 A native of Columbus, Ohio, she has lived in the Washington, D.C. area for over 35 years and currently resides in Bethesda, Maryland, with her family.1

Recent Activities

Finan has been actively involved in Sabin's efforts to combat infectious diseases:

• She recently visited Rwanda's Marburg Command Post, supporting the country's efforts to manage the Marburg virus outbreak2
• Under her leadership, Sabin delivered over 1,700 doses of the Marburg virus vaccine to protect frontline health workers in Rwanda2

Amy Finan continues to lead Sabin Vaccine Institute in its mission to make vaccines more accessible and expand immunization across the globe.13